Oncology Corporate Profile
XEME Biopharma is a clinical-stage Company focused on developing therapeutic products under the guidance of the Food and Drug Administration (FDA) in the area of active cancer immunotherapy (vaccines). This area of therapeutic cancer vaccines is expected by many oncology specialists to provide the next breakthrough in the treatment of cancer beyond the current approaches of surgery, radiation, chemotherapy and passive immunotherapy (monoclonal antibodies).
|Brand / Product||Class||Area of Study||Phase||Partnership|
|Oncoquest?||personalized cancer vaccine||Non-Hodgkin's Lymphoma (NHL)||II|
|Oncoquest?||personalized cancer vaccine||Chronic Lymphocytic Leukemia (CLL)||I|
View additional information on product candidates here »